Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

UNKNOWN × Therapeutics × Breast × Clear all

Status

Sponsor Class

OTHER 32 INDUSTRY 4 NIH 3 NETWORK 2 UNKNOWN 1

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1

Interventions

Paclitaxel 6 Epirubicin 6 Capecitabine 6 pyrotinib 5 Carboplatin 5 Vinorelbine 4 Docetaxel 4 Cyclophosphamide 4 anlotinib 3 Radiotherapy 3 Radiation Dose Hypofractionation 3 Fulvestrant 3 Etoposide 3 pirarubicin 2 exemestane 2 apatinib 2 Standard of Care 2 Neoadjuvant Therapy 2 Albumin-Bound Paclitaxel 2 toripalimab 1 palbociclib 1 neratinib 1 lobaplatin 1 liposomal doxorubicin 1 icaritin 1 eribulin 1 Zoledronic Acid 1 Trastuzumab 1 Therapeutics 1 S 1 (combination) 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05068115 2021-10-13

Characteristics and Treatment Trends of Young Breast Cancer in China

ChineseAMS

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡